{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:36:29Z","timestamp":1790750189701,"version":"4.1.0"},"reference-count":32,"publisher":"Society of Nuclear Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.2967\/jnumed.117.206920","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T19:50:16Z","timestamp":1517514616000},"page":"1380-1385","source":"Crossref","is-referenced-by-count":19,"title":["<sup>18<\/sup>F-Fludarabine PET for Lymphoma Imaging: First-in-Humans Study on DLBCL and CLL Patients"],"prefix":"10.2967","volume":"59","author":[{"given":"Sylvain","family":"Chantepie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narin\u00e9e","family":"Hovhannisyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Guillouet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Pelage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9ziane","family":"Ibazizene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Bodet-Milin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Carlier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Claire","family":"Gac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"R\u00e9boursi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Vilque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Kraeber-Bod\u00e9r\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Manrique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gandhi","family":"Damaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Leporrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"Barr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2018,2,1]]},"reference":[{"key":"2021051712122520000_59.9.1380.1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569"},{"key":"2021051712122520000_59.9.1380.2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cpet.2011.12.002","article-title":"Novel PET radiotracers for potential use in management of lymphoma","volume":"7","author":"Kostakoglu","year":"2012","journal-title":"PET Clin."},{"key":"2021051712122520000_59.9.1380.3","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.3390\/cancers6041821","article-title":"Positron Emission Tomography (PET) in oncology","volume":"6","author":"Gallamini","year":"2014","journal-title":"Cancers (Basel)."},{"key":"2021051712122520000_59.9.1380.4","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1200\/JCO.2016.68.6394","article-title":"Early positron emission tomography response-adapted treatment in stage I and II Hodgkin lymphoma: final results of the randomized EORTC\/LYSA\/FIL H10 trial","volume":"35","author":"Andr\u00e9","year":"2017","journal-title":"J Clin Oncol."},{"key":"2021051712122520000_59.9.1380.5","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12601"},{"key":"2021051712122520000_59.9.1380.6","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2973-6"},{"key":"2021051712122520000_59.9.1380.7","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3389\/fonc.2013.00212","article-title":"State-of-the-art research on \u201clymphomas: role of molecular imaging for staging, prognostic evaluation, and treatment response.\u201d","volume":"3","author":"Kostakoglu","year":"2013","journal-title":"Front Oncol."},{"key":"2021051712122520000_59.9.1380.8","first-page":"1972","article-title":"Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography","volume":"33","author":"Kubota","year":"1992","journal-title":"J Nucl Med."},{"key":"2021051712122520000_59.9.1380.9","doi-asserted-by":"publisher","DOI":"10.1148\/rg.251045045"},{"key":"2021051712122520000_59.9.1380.10","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23423"},{"key":"2021051712122520000_59.9.1380.11","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.3109\/10428194.2013.869801","article-title":"Use of positron emission tomography-computed tomography in the management of patients with chronic lymphocytic leukemia\/small lymphocytic lymphoma","volume":"55","author":"Conte","year":"2014","journal-title":"Leuk Lymphoma."},{"key":"2021051712122520000_59.9.1380.12","first-page":"4","article-title":"PET\/CT appropriate application in lymphoma","volume":"4","author":"Wang","year":"2015","journal-title":"Chin Clin Oncol."},{"key":"2021051712122520000_59.9.1380.13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11307-013-0657-4","article-title":"Fully automated radiosynthesis of 2-[18F]fludarabine for PET imaging of low-grade lymphoma","volume":"16","author":"Guillouet","year":"2014","journal-title":"Mol Imaging Biol."},{"key":"2021051712122520000_59.9.1380.14","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241020-00002"},{"key":"2021051712122520000_59.9.1380.15","doi-asserted-by":"publisher","DOI":"10.1586\/14737140.6.9.1141"},{"key":"2021051712122520000_59.9.1380.16","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20483"},{"key":"2021051712122520000_59.9.1380.17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bcp.2015.01.010","article-title":"The purine analog fludarabine acts as a cytosolic 5\u2032-nucleotidase II inhibitor","volume":"94","author":"Cividini","year":"2015","journal-title":"Biochem Pharmacol."},{"key":"2021051712122520000_59.9.1380.18","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s11307-013-0659-2","article-title":"2-[18F]fludarabine, a novel positron emission tomography (PET) tracer for imaging lymphoma: a micro-PET study in murine models","volume":"16","author":"Dhilly","year":"2014","journal-title":"Mol Imaging Biol."},{"key":"2021051712122520000_59.9.1380.19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13550-015-0101-7","article-title":"Evaluation of the specificity of [18F]fludarabine PET\/CT in a xenograft model of follicular lymphoma: comparison with [18F]FDG and impact of rituximab therapy","volume":"5","author":"Hovhannisyan","year":"2015","journal-title":"EJNMMI Res."},{"key":"2021051712122520000_59.9.1380.20","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1021\/acs.molpharmaceut.6b00050","article-title":"Comparative analysis between [18F]fludarabine-PET and [18F]FDG-PET in a murine model of inflammation","volume":"13","author":"Hovhannisyan","year":"2016","journal-title":"Mol Pharm."},{"key":"2021051712122520000_59.9.1380.21","first-page":"6201","article-title":"The role of fludarabine-induced apoptosis and cell cycle synchronization in enhanced murine tumor radiation response in vivo","volume":"54","author":"Gr\u00e9goire","year":"1994","journal-title":"Cancer Res."},{"key":"2021051712122520000_59.9.1380.22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-093906"},{"key":"2021051712122520000_59.9.1380.23","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-01-293050"},{"key":"2021051712122520000_59.9.1380.24","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.057307"},{"key":"2021051712122520000_59.9.1380.25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800"},{"issue":"suppl","key":"2021051712122520000_59.9.1380.26","first-page":"37S","article-title":"MIRD pamphlet no. 16: techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates","volume":"40","author":"Siegel","year":"1999","journal-title":"J Nucl Med."},{"key":"2021051712122520000_59.9.1380.27","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/j.ejrad.2016.08.011","article-title":"Proportion of false-positive lesions at interim and end-of-treatment FDG-PET in lymphoma as determined by histology: systematic review and meta-analysis","volume":"85","author":"Adams","year":"2016","journal-title":"Eur J Radiol."},{"key":"2021051712122520000_59.9.1380.28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12149-015-1047-6","article-title":"18F-FDG and 18F-FLT PET\/CT imaging in the characterization of mediastinal lymph nodes","volume":"30","author":"Rayamajhi","year":"2016","journal-title":"Ann Nucl Med."},{"key":"2021051712122520000_59.9.1380.29","doi-asserted-by":"publisher","DOI":"10.1124\/pr.110.002790"},{"key":"2021051712122520000_59.9.1380.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2011.01.007"},{"key":"2021051712122520000_59.9.1380.31","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-012-1640-x"},{"key":"2021051712122520000_59.9.1380.32","doi-asserted-by":"publisher","DOI":"10.1007\/s13246-011-0119-8"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.117.206920","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T20:29:13Z","timestamp":1621283353000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.117.206920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,1]]},"references-count":32,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9,4]]},"published-print":{"date-parts":[[2018,9]]}},"alternative-id":["10.2967\/jnumed.117.206920"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.117.206920","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,1]]}}}